A prospective randomized clinical trial conducted at Shanghai East Hospital has evaluated whether a remifentanil-intensive conscious sedation strategy reduces respiratory complications compared with conventional propofol-based deep sedation among geriatric patients undergoing same-visit bidirectional endoscopy. In the investigation, 458 elderly patients scheduled for concurrent esophagogastroduodenoscopy and colonoscopy were randomized to receive either conscious sedation or standard deep sedation. The researchers recorded an incidence of oxygen desaturation of 4.0 percent, or 9 of 224 individuals, among patients managed with the conscious sedation strategy, compared with 10.2 percent, representing 23 of 225 patients, in the deep sedation cohort. The unadjusted comparison yielded an odds ratio of 0.37 with a 95 percent confidence interval spanning 0.17 to 0.81, corresponding to a risk ratio of 0.39 with a 95 percent confidence interval from 0.19 to 0.83, and an absolute risk reduction of 6.2 percentage points with a 95 percent confidence interval from minus 10.9 percent to minus 1.5 percent. These findings, derived from the principal completed-protocol analysis population, indicated that relying on higher relative doses of remifentanil while lowering propofol exposure lowered the frequency of transient arterial hypoxemia under supplemental oxygen in this geriatric procedural setting.
Gastrointestinal endoscopy in elderly individuals presents persistent clinical dilemmas regarding procedural safety, patient comfort, and the depth of pharmacological depression. Advanced age represents an established independent predisposing factor for adverse events during sedation, with older adults exhibiting heightened susceptibility to drug-induced cardiorespiratory depression, upper airway obstruction, and hemodynamic volatility. Bidirectional endoscopy combines upper esophagogastroduodenoscopy and lower colonoscopy into a single continuous clinical session, lengthening overall procedural time and multiplying the noxious stimuli encountered across disparate anatomical sites. Standard clinical practice frequently relies on deep propofol sedation augmented with small opioid boluses to ensure patient immobility and procedure tolerability. While propofol delivers swift sedation and dependable hypnosis, its dose-dependent depression of central respiratory drive and systemic vascular resistance generates frequent episodes of arterial oxygen desaturation and arterial hypotension. Anesthesiologists frequently encounter situations where counteracting somatic discomfort with escalating propofol doses compromises baseline spontaneous ventilation, creating an impetus to examine alternative pharmacological approaches that decrease the sedative burden while maintaining adequate procedural analgesia.
The central pharmacological thesis underlying this single-center investigation involved shifting the primary anesthetic mechanism from deep hypnotic suppression to intensive opioid analgesia maintained at a lighter conscious sedation plane. Conscious sedation was defined as achieving a score of 3 to 4 on the Modified Observer’s Assessment of Alertness and Sedation scale, a state in which patients retain purposeful responsiveness to verbal stimuli. Deep sedation, by contrast, targeted a score of 1 to 2, rendering patients completely unresponsive to spoken commands. The trial protocol leveraged remifentanil, an ultra-short-acting synthetic opioid characterized by rapid onset, a context-sensitive half-life of several minutes, and organ-independent elimination via nonspecific tissue and blood esterases. By supplying robust suppression of visceral nociception and airway reflexes with remifentanil, the clinicians aimed to minimize the supplementary propofol required to achieve adequate examination tolerance. Because conscious patients retain sufficient neuromuscular tone and cortical responsiveness to answer verbal cues, attending clinicians could prompt deep spontaneous inhalations whenever minor respiratory slowing was observed, potentially avoiding progressive desaturation without requiring chemical antagonists.
Patient recruitment took place between June 2, 2025, and April 21, 2026, enrolling participants aged 65 years or older classified as American Society of Anesthesiologists Physical Status I through IV. Prospective participants were excluded if they required advanced therapeutic endoscopic interventions anticipated to exceed 30 minutes, presented with severe neuropsychiatric or cerebrovascular disorders, required endotracheal intubation, or had uncontrolled arterial hypertension above 160 mmHg systolic or 100 mmHg diastolic. The trial also excluded individuals with recent opioid or benzodiazepine exposure within four weeks, prior adverse reactions to study medications, or substance abuse histories. Eligible participants underwent stratified block randomization in a 1 to 1 allocation ratio, stratified by age above or below 75 years and American Society of Anesthesiologists status between grades I to II versus III to IV, utilizing sequentially numbered, opaque, sealed envelopes prepared by an independent statistician. The observed cohort ranged from 65 to 97 years of age, with 11.8 percent of participants exceeding 80 years. Baseline characteristics between the groups were balanced across age, sex distribution, body mass index, baseline blood pressure, and cognitive status, with standardized mean differences remaining below 0.15 across measured pre-intervention covariates.
All participating patients underwent standard pre-procedural monitoring, including three baseline blood pressure measurements taken after five minutes of resting recumbency, continuous pulse oximetry, electrocardiographic tracking, and non-invasive blood pressure readings obtained every three minutes on the right upper arm. Supplemental oxygen was delivered at a uniform flow rate of 6 liters per minute via nasal cannula while patients rested in the left lateral position. Pharyngeal topical anesthesia was achieved with 100 milligrams of dyclonine spray before induction. In the conscious sedation cohort, induction comprised an initial intravenous remifentanil bolus of 0.5 micrograms per kilogram followed by propofol titrated at 0.2 milligrams per kilogram increments toward the target score of 3 to 4. Maintenance boluses of 10 micrograms of remifentanil or 10 milligrams of propofol were administered every three to five minutes as clinically indicated. Conversely, the deep sedation group received an induction bolus of 0.2 micrograms per kilogram of remifentanil followed by propofol boluses of 0.5 milligrams per kilogram to establish a score of 1 to 2, maintained with intermittent boluses of 5 micrograms of remifentanil or 20 milligrams of propofol. Depth was formally verified every two to three minutes by the attending anesthesiologist throughout the procedure.
The study protocol established the primary outcome as the cumulative incidence of arterial oxygen desaturation, defined as a pulse oximeter saturation reading dropping below 90 percent for ten consecutive seconds or longer from the onset of anesthetic induction through discharge from the post-anesthesia care unit. Among the 449 patients who completed their allocated sedation strategy, 9 of 224 individuals in the conscious sedation arm and 23 of 225 individuals in the deep sedation arm reached this primary endpoint. Multivariable logistic regression adjusting for prespecified baseline covariates—including participant age, sex, American Society of Anesthesiologists classification, body mass index, baseline hypertension, and active tobacco smoking—yielded an adjusted odds ratio of 0.36 with a 95 percent confidence interval of 0.16 to 0.81 and a risk difference of minus 6.1 percent, matching the unadjusted primary analysis. A supportive Firth penalized logistic regression analysis similarly demonstrated an adjusted odds ratio of 0.38 with a 95 percent confidence interval from 0.17 to 0.82. In all affected individuals, desaturation episodes initiated intraprocedurally rather than in the recovery unit.
The investigation evaluated a wide range of secondary cardiorespiratory endpoints, highlighting distinct physiological profiles between the two sedation regimens. A prespecified composite secondary endpoint encompassing either oxygen desaturation or arterial hypotension developed in 9.8 percent of conscious sedation patients, or 22 of 224 individuals, compared with 26.7 percent of deep sedation patients, representing 60 of 225 individuals, yielding an odds ratio of 0.30 with a 95 percent confidence interval of 0.18 to 0.51 and an adjusted false discovery rate q-value below 0.001. Isolated arterial hypotension, defined as systolic blood pressure dropping below 80 mmHg or decreasing by more than 30 percent from pre-procedure baseline, occurred in 6.2 percent of the conscious group versus 20.0 percent of the deep group. In contrast, the secondary rates of post-procedure delirium documented in the recovery unit via the Confusion Assessment Method were 0.9 percent in the conscious cohort and 5.3 percent in the deep sedation cohort, with an adjusted q-value of 0.02. Delirium assessed 24 hours post-procedure was low and did not differ statistically, observed in zero conscious patients and three deep sedation patients. Minor adverse effects, including post-procedural nausea, vomiting, headache, and dizziness, demonstrated comparable frequencies between the study groups.
Procedural timelines and pharmacological consumption patterns diverged sharply between the assigned groups. Induction time was longer in the conscious sedation arm, requiring a mean of 81.4 seconds compared with 55.3 seconds in the deep sedation arm, generating a mean difference of 26.1 seconds. However, total procedure duration remained nearly identical, averaging 15.6 minutes in the conscious sedation group and 16.2 minutes in the deep sedation cohort. Patients managed under conscious sedation exhibited faster emergence, demonstrating a median awake time of 3 minutes compared with 6 minutes for deep sedation, and achieved post-anesthesia discharge criteria faster, with a median recovery duration of 8 minutes versus 12 minutes. Total propofol requirements were substantially lower in the conscious sedation cohort, with patients receiving a median total dose of 66 milligrams compared with 168 milligrams under deep sedation, yielding a median difference of minus 102 milligrams. Conversely, remifentanil utilization was higher in the conscious cohort, with a median total consumption of 84 micrograms versus 40 micrograms in the deep sedation cohort.
Endoscopic procedural quality indicators and patient-centered satisfaction metrics provided further insight into the clinical feasibility of maintaining lighter anesthesia during bidirectional examinations. Cecal intubation rates remained high across both treatment arms, reaching 97.3 percent in the conscious sedation arm and 98.2 percent in the deep sedation arm. Polyp detection rates stood at 33.0 percent versus 34.7 percent, while adenoma detection rates were 14.3 percent and 12.0 percent respectively, showing no statistically significant disparities. However, attending endoscopist satisfaction was statistically significantly lower in the conscious sedation cohort, with 92.4 percent of clinicians reporting high satisfaction compared with 97.8 percent in the deep sedation cohort, corresponding to an odds ratio of 0.28 with a 95 percent confidence interval of 0.10 to 0.76 and a q-value of 0.02. The investigators suggested that this slight decrement in operator contentment might stem from persistent colonic peristalsis or mild patient repositioning movements that occur when hypnosis is lightened. Patient-reported assessments remained uniformly positive, with 95.5 percent of conscious sedation participants and 96.0 percent of deep sedation participants reporting high personal satisfaction, while willingness to repeat the assigned sedation protocol did not differ significantly between cohorts.
Prespecified subgroup assessments revealed an exploratory interaction between patient age and the reduction in oxygen desaturation. In participants aged 75 years or older, conscious sedation was associated with a marked reduction in desaturation events, occurring in 1.2 percent of conscious patients compared with 16.7 percent of deep sedation patients, yielding an odds ratio of 0.06 with a 95 percent confidence interval from 0.01 to 0.47. In contrast, among participants younger than 75 years, event rates were 5.7 percent versus 6.8 percent, producing an odds ratio of 0.83 with a 95 percent confidence interval from 0.32 to 2.17. The interaction test reached a nominal significance level of P equals 0.01. Subgroup analyses stratified across sex, body mass index categories, American Society of Anesthesiologists functional grades, baseline hypertension status, and total procedure duration did not identify significant effect modification. Because these subgroup calculations involved small stratum event numbers and were conducted without adjustment for multiple testing, investigators highlighted that these subgroup observations must be viewed as hypothesis-generating observations rather than definitive practice standards.
The study investigators detailed several methodological constraints and execution nuances that contextualize their reported findings. First, the open-label design created an inherent lack of clinical blinding among bedside personnel, which could introduce performance bias, although primary outcome assessment relied on continuous objective pulse oximetry thresholds. Second, intraprocedural capnography was not utilized to quantify end-tidal carbon dioxide concentrations, and attained sedation levels were not tracked continuously between intermittent scoring windows. Consequently, while the protocol documented a lower incidence of desaturation under high-flow nasal oxygen, it could not directly verify preserved ventilatory drive or guarantee comprehensive respiratory safety. Third, recruitment exceeded the initial sample size of 340 individuals registered with the Chinese Clinical Trial Registry, expanding to 458 participants based on the principal investigator’s operational intent to compensate for potential dropouts, an expansion documented without contemporaneous registry updates. While retrospective ethics review acknowledged this enrollment adjustment, the modification was filed after recruitment conclusion.
Furthermore, analytical definitions regarding missing data highlighted statistical vulnerabilities in the study conclusions. Three patients who required conversion to general anesthesia because of complex polyps were omitted from the primary 449-patient cohort; retaining these three individuals in a protocol-aligned treatment-policy analysis of 452 participants produced an odds ratio of 0.37 with a 95 percent confidence interval of 0.17 to 0.82. However, sensitivity models exploring the six pre-induction consent withdrawals revealed that statistical significance was sensitive to outcome imputation assumptions. In an all-missing-as-events sensitivity scenario, the odds ratio rose to 0.49 with a 95 percent confidence interval of 0.24 to 0.99 and a Fisher exact P-value of 0.061. Under a worst-case imputation scenario attributing desaturation events to conscious dropouts and non-events to deep dropouts, the odds ratio became 0.54 with a 95 percent confidence interval spanning 0.27 to 1.09 and a P-value of 0.117. In summary, while the trial demonstrated that a remifentanil-intensive conscious sedation approach reduced observed desaturation events and propofol requirements alongside faster post-anesthesia recovery in elderly endoscopy patients, confirmation across multicenter cohorts with dedicated respiratory monitoring remains necessary.
Subject of Research: Sedation protocols and oxygen desaturation during elderly bidirectional endoscopy
Article Title: Remifentanil-intensive conscious sedation versus conventional deep sedation for oxygen desaturation in elderly patients undergoing bidirectional endoscopy: a randomized clinical trial
Article References: Liu, F., Tang, B., Wang, X., Shen, W., Yuan, Q., Zhang, Y., Guan, Z., Liu, Z., Ding, Z., & Yang, L. (2026). Remifentanil-intensive conscious sedation versus conventional deep sedation for oxygen desaturation in elderly patients undergoing bidirectional endoscopy: a randomized clinical trial. Frontiers in Medicine, 13, Article 1939742. https://doi.org/10.3389/fmed.2026.1939742
Image Credits: AI Generated
DOI: 10.3389/fmed.2026.1939742
Keywords: remifentanil, propofol, conscious sedation, deep sedation, oxygen desaturation, elderly patients, bidirectional endoscopy, Shanghai East Hospital, hypotension, anesthesiology, gastrointestinal endoscopy, Modified Observer's Assessment of Alertness, PACU recovery, sedation safety, randomized clinical trial, postoperative delirium, airway management, endoscopy quality metrics
News Source: Ophelia Keating. (November 19, 2026). Conscious Sedation Cuts Oxygen Desaturation in Elderly Endoscopy Patients. Scienmag.



